Longform.ai BV, a spin-off from the University of Amsterdam (UvA) and based in Amsterdam, has secured €300,000 in funding from Innovatiefonds Noord-Holland. In addition, the company has benefited from extensive mentorship provided by the TTT-AI program, accelerating both its research and commercialization efforts.
Longform.ai is building a cutting-edge platform that leverages generative AI to extract valuable insights from large volumes of audio data. As online conversations like podcasts and webinars continue to grow rapidly, they are becoming a vital source of information for analysts, researchers, and business leaders. However, the sheer volume of content presents a challenge: with thousands of hours of conversations to sift through, identifying the most relevant information can be overwhelming. Longform.ai addresses this problem by using advanced AI technology to efficiently analyze and interpret key data and insights from massive audio datasets.
TTT-AI (TTT-AI.nl) & IXA business developers and legal advisors helped Longform.ai to get Proof of Concept funding and to arrange an IP agreement with UVA.
For more information: Pim Stouten, Co-Founder longform.ai, pim@longform.ai, Annemmieke de Raad, Business Developer AI @ IXA, A.deraad@uva.nl
The Thematic Technology Transfer Artificial Intelligence (TTT-AI) is a knowledge and investment consortium consisting of several Dutch universities and academic hospitals. Formed in 2020, the consortium’s aim is to advance the availability of artificial intelligence innovations within society. TTT-AI enables researchers to take their research-based ideas to the next level, validate them, and establish successful spin-offs.
Amsterdam researchers have secured Biotech Booster funding for a total of six projects, that include a promising cancer treatment, a new diagnostic method for Alzheimer’s Disease, an implant helping blindness, lab innovation in biotechnology, and a nutritional intervention for mental health. The researchers will develop a solid business case for their innovations in the time […]
NewsVU-AMS is on a mission to revolutionize how we understand and manage stress-related health issues. Now an official VU spin-off, there are big plans for clinical applications. Founder of VU AMS Martin Gevonden explains: “We offer researchers autonomic biomarkers that are valid, reliable and easy to use, without getting under the skin.” After thriving in […]
NewsPULSE Sport, a start-up from the Demonstrator Lab, has reached a significant milestone by winning the prestigious 14th Dutch Sports Innovation Award. The company’s flagship product, a cutting-edge athlete management system, integrates advanced software and artificial intelligence to revolutionize athlete health and performance monitoring. About the Innovation PULSE Sport’s athlete management system provides a holistic […]
News